Cargando…
Monitoring compliance with Clinical Protocol and Therapeutic Guidelines for Alzheimer’s disease
Dementia is a chronic neurodegenerative disease and Alzheimer’s disease (AD) is the most prevalent type. OBJECTIVE: To describe the drug monitoring of patients enrolled in a Clinical Protocol and Therapeutic Guidelines of Alzheimer’s Disease (PCDTDA) in Brazil. METHODS: A descriptive study based on...
Autores principales: | Forgerini, Marcela, Mastroianni, Patrícia de Carvalho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação de Neurologia Cognitiva e do
Comportamento
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077856/ https://www.ncbi.nlm.nih.gov/pubmed/32206194 http://dx.doi.org/10.1590/1980-57642020dn14-010004 |
Ejemplares similares
-
Risk factors associated with drug therapy among elderly people with Alzheimer’s disease: a cross-sectional study
por: Forgerini, Marcela, et al.
Publicado: (2020) -
Drug administration adjustments for elderly patients with dysphagia: A case report
por: Mastroianni, Patrícia de Carvalho, et al.
Publicado: (2018) -
Safety assessment of omeprazole use: a review
por: Forgerini, Marcela, et al.
Publicado: (2018) -
Assessment of the adherence to and costs of the prophylaxis protocol for venous thromboembolism
por: Forgerini, Marcela, et al.
Publicado: (2019) -
Clinical pharmacy services in Brazil, particularly cardiometabolic
diseases: a systematic scoping review and meta-analyses
por: Nassur, Priscila L., et al.
Publicado: (2020)